Revolutionary new cancer therapies come with big risks. Drug makers must be prepared – STAT
STAT |
Revolutionary new cancer therapies come with big risks. Drug makers must be prepared
STAT These new drugs, the first in the new family of CAR–T cell therapies 3, could revolutionize the treatment of blood cancers and make inroads into the treatment of solid tumors. They work by isolating immune cells 4 known as T cells from a patient's … Cellectis gets FDA go-ahead to restart fatal CAR–T trial |
